33.81
Tg Therapeutics Inc 주식(TGTX)의 최신 뉴스
TG Therapeutics (TGTX) Margin Miss Challenges Growth-Driven Profitability Narrative - Yahoo Finance
TG Therapeutics (NASDAQ:TGTX) Given New $49.00 Price Target at JPMorgan Chase & Co. - MarketBeat
TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised - Nasdaq
TG Therapeutics (TGTX): Exploring Valuation as Growth Prospects Spark Investor Interest - Yahoo Finance
TG Therapeutics (NASDAQ:TGTX) Announces Quarterly Earnings Results, Beats Estimates By $2.19 EPS - MarketBeat
Tools to assess TG Therapeutics Inc.’s risk profileMarket Activity Report & Safe Investment Capital Preservation Plans - newser.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2025 Earnings Call Transcript - Insider Monkey
Hussman Strategic Advisors Inc. Grows Position in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics: Q3 Earnings Snapshot - theheraldreview.com
HC Wainwright Predicts Reduced Earnings for TG Therapeutics - MarketBeat
TG Therapeutics (TGTX) Financials 2025Income Statement and Balance Sheet - MarketBeat
TG Therapeutics (TGTX) 10K Form and SEC Filings 2025 - MarketBeat
Will TG Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Chart Watch & Free Technical Pattern Based Buy Signals - newser.com
How TG Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com
Building trade automation scripts for TG Therapeutics Inc.July 2025 Sentiment & Verified Momentum Watchlists - newser.com
JP Morgan Maintains TG Therapeutics (TGTX) Overweight Recommendation - MSN
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo! Finance UK
How to build a dashboard for TG Therapeutics Inc. stockJuly 2025 Movers & Weekly High Return Opportunities - newser.com
TG Therapeutics raises BRIUMVI 2025 revenue guidance to $585M while advancing subcutaneous pipeline - MSN
Is now a turning point for TG Therapeutics Inc.Short Setup & Daily Risk Controlled Trade Plans - newser.com
TG Therapeutics Inc (TGTX) Q3 2025 Earnings Call Highlights: Rec - GuruFocus
TG Therapeutics Inc (TGTX) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ... - Yahoo Finance
TG Therapeutics (TGTX) Stock Chart and Price History 2025 - MarketBeat
TG Therapeutics (TGTX) Earnings Date and Reports 2025 - MarketBeat
TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics, Inc. Raises Earnings Guidance for the Year 2025 - MarketScreener
TG Therapeutics (TGTX) Reports Strong Q3 2025 Results Driven by BRIUMVI - GuruFocus
TG Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat
Transcript : TG Therapeutics, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
TGTX: JP Morgan Raises Price Target to $49, Maintains Overweight Rating | TGTX Stock News - GuruFocus
Earnings call transcript: TG Therapeutics Q3 2025 beats EPS forecast, stock dips - Investing.com Canada
Earnings call transcript: TG Therapeutics Q3 2025 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa
TG Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug - Stocktwits
TG Therapeutics, Inc. (TGTX) Q3 FY2025 earnings call transcript - Yahoo Finance
TG Therapeutics (TGTX) Reports Strong Q3, Raises 2025 Revenue Gu - GuruFocus
TG Therapeutics (TGTX) Stock Price, News & Analysis - MarketBeat
TG Therapeutics Inc (TGTX) Reports Q3 2025 Revenue of $161.7 Mil - GuruFocus
TG Therapeutics (TGTX) Increases 2025 BRIUMVI Revenue Forecast - GuruFocus
TG Therapeutics (TGTX) Surpasses Q3 Revenue Expectations and Exp - GuruFocus
TG Therapeutics Q3 Earnings: $390.9M Net Income, Beats ForecastsNews and Statistics - IndexBox
[8-K] TG THERAPEUTICS, INC. Reports Material Event | TGTX SEC FilingForm 8-K - Stock Titan
TG Therapeutics Q3 Net Income, Revenue Rise; Raises 2025 Revenue Guidance - MarketScreener
Earnings Flash (TGTX) TG Therapeutics Posts Q3 EPS $2.43, vs. FactSet Est of $0.22 - MarketScreener
Earnings Flash (TGTX) TG Therapeutics, Inc. Reports Q3 Revenue $161.7M, vs. FactSet Est of $152.1M - MarketScreener
TG Therapeutics Q3 revenue up on strong demand, raises 2025 forecast - MarketScreener
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance - Stock Titan
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update - MarketScreener
Analyzing recovery setups for TG Therapeutics Inc. investorsJuly 2025 Price Swings & Short-Term Swing Trade Alerts - newser.com
What dividend safety score for TG Therapeutics Inc. stockTrade Performance Summary & Risk Controlled Swing Alerts - newser.com
TG Therapeutics Builds On BRIUMVI's Momentum Ahead Of Q3 Earnings And 2027 Launch Plans - RTTNews
Can TG Therapeutics Inc. stock resist market sell offsWall Street Watch & Long-Term Capital Growth Strategies - newser.com
Is it time to cut losses on TG Therapeutics Inc.Dividend Hike & Daily Chart Pattern Signal Reports - newser.com
Is TG Therapeutics Inc. stock oversold or undervaluedJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
자본화:
|
볼륨(24시간):